Millennium Management’s Lisata Therapeutics LSTA Stock Holding History

Millennium Management’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,327	Closed	-$104K	–	7061
2021 Q2	$104K	Buy	4,327 +1,367	+46%	+$32.4K	﹤0.01%	6222
2021 Q1	$86K	Buy	+2,960	New	+$89.7K	﹤0.01%	5712
2020 Q4	–	Sell	-1,644	Closed	-$44	–	5422
2020 Q3	$44	Buy	+1,644	New	+$52K	﹤0.01%	4304
2018 Q2	–	Sell	-708	Closed	-$62K	–	4008
2018 Q1	$62K	Buy	+708	New	+$49K	﹤0.01%	3522
2016 Q1	–	Sell	-1,319	Closed	-$214K	–	3496
2015 Q4	$214K	Buy	1,319 +535	+68%	+$98.2K	﹤0.01%	3060
2015 Q3	$175K	Sell	784 -376	-32%	-$94.3K	﹤0.01%	3155
2015 Q2	$325K	Buy	1,160 +1,075	+1,265%	+$399K	﹤0.01%	2846
2015 Q1	$32K	Sell	85 -476	-85%	-$258K	﹤0.01%	3491
2014 Q4	$317K	Buy	+561	New	+$382K	﹤0.01%	3313
2014 Q3	–	Sell	-70	Closed	-$68K	–	3868
2014 Q2	$68K	Buy	+70	New	+$68.1K	﹤0.01%	3286

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Millennium Management's LSTA Position: Q3 2021 in Review

Millennium Management sold out of Lisata Therapeutics (LSTA) in Q3 2021, closing a stake of 4,327 shares — an estimated $104K sold.

Millennium Management first reported a position in LSTA in Q2 2014 and held it in 10 quarters. The position peaked at $325K in Q2 2015. 32 funds tracked by Wall St. Rank hold LSTA as of Q3 2021.

Millennium Management reported no remaining Lisata Therapeutics position as of Q3 2021 after selling out during the quarter.
Millennium Management sold 4,327 Lisata Therapeutics shares in Q3 2021, an estimated $104K.
Millennium Management first reported a position in Lisata Therapeutics in Q2 2014 and held it in 10 quarters.
Millennium Management's Lisata Therapeutics position peaked at $325K in Q2 2015.
32 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.